Thais L. Monte
Porto Alegre, RS, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Profile and outcomes of Parkinson's disease deep brain stimulation in a public tertiary center in Brazil: retrospective cohort.
Journal: Arquivos de neuro-psiquiatria
Published: July 21, 2026
Juvenile mitochondrial membrane protein-associated neurodegeneration with early parkinsonism and obsessive-compulsive behavior.
Journal: Parkinsonism & related disorders
Published: June 29, 2026
Healthcare delay in neurogenetic disorders of adult onset and the role of predictive genetic testing.
Journal: Journal of community genetics
Published: October 08, 2024
The progression rate of spinocerebellar ataxia type 2 changes with stage of disease.
Journal: Orphanet journal of rare diseases
Published: July 05, 2017
NESSCA Validation and Responsiveness of Several Rating Scales in Spinocerebellar Ataxia Type 2.
Journal: Cerebellum (London, England)
Published: May 01, 2017
Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Journal: Frontiers in neurology
Published: March 10, 2017
Neurological phenotypes in spinocerebellar ataxia type 2: Role of mitochondrial polymorphism A10398G and other risk factors.
Journal: Parkinsonism & related disorders
Published: January 04, 2017
Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis.
Journal: Journal of neurology
Published: January 15, 2016
Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3.
Journal: Cerebellum (London, England)
Published: September 24, 2015
Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial.
Journal: Journal of the neurological sciences
Published: June 23, 2015
ATXN3, ATXN7, CACNA1A, and RAI1 Genes and Mitochondrial Polymorphism A10398G Did Not Modify Age at Onset in Spinocerebellar Ataxia Type 2 Patients from South America.
Journal: Cerebellum (London, England)
Published: April 15, 2015
A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: June 15, 2013
Last Updated: 09/26/2026